Turn Therapeutics releases updated investor presentation under Regulation FD

Filed June 3, 2026 · Period ending June 3, 2026 · ~1 min read

Key Changes

• medium

  Company furnished an updated investor presentation dated June 3, 2026, under Regulation FD disclosure rules. The 8-K filing itself does not describe the presentation's content.

  Item 7.01 verify on EDGAR →
• low

  This is a routine disclosure filing with no operational or financial events announced. Investors should review the presentation exhibit directly for any material updates.

  8-K: Reg FD Disclosure verify on EDGAR →